Cargando…

Volume of distribution as an early predictor of vancomycin-induced AKI in critically ill patients

Detalles Bibliográficos
Autores principales:	Ghasemiyeh, Parisa, Vazin, Afsaneh, Zand, Farid, Mohammadi-Samani, Soliman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2023
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644930/ https://www.ncbi.nlm.nih.gov/pubmed/37850781 http://dx.doi.org/10.23750/abm.v94i5.14158

Ejemplares similares

Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters
por: Ghasemiyeh, Parisa, et al.
Publicado: (2022)

A simple and validated HPLC method for vancomycin assay in plasma samples: the necessity of TDM center development in Southern Iran
por: Ghasemiyeh, Parisa, et al.
Publicado: (2020)

A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines
por: Ghasemiyeh, Parisa, et al.
Publicado: (2021)

Major Neurologic Adverse Drug Reactions, Potential Drug–Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review
por: Ghasemiyeh, Parisa, et al.
Publicado: (2020)

The necessity of early anti-inflammatory therapy initiation in cases with mild-to-moderate COVID-19: A personal experience from an attending pharmacist and his resident
por: Parisa, Ghasemiyeh, et al.
Publicado: (2021)

Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages
por: Ghasemiyeh, Parisa, et al.
Publicado: (2018)

Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
por: Ghasemiyeh, Parisa, et al.
Publicado: (2020)

COVID-19 outbreak: Challenges in pharmacotherapy based on pharmacokinetic and pharmacodynamic aspects of drug therapy in patients with moderate to severe infection
por: Ghasemiyeh, Parisa, et al.
Publicado: (2020)

Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications
por: Ghasemiyeh, Parisa, et al.
Publicado: (2021)

Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
por: Firouzabadi, Negar, et al.
Publicado: (2023)

Fluid accumulation increases the risk of AKI progression and death in critically ill patients with early AKI
por: Raimundo, MR, et al.
Publicado: (2014)

Optimization, characterization, and follicular targeting assessment of tretinoin and bicalutamide loaded niosomes
por: Ghasemiyeh, Parisa, et al.
Publicado: (2023)

Nutrition Support in Critically Ill Patients with AKI
por: Ramakrishnan, Nagarajan, et al.
Publicado: (2020)

Artemether-loaded nanostructured lipid carriers: preparation, characterization, and evaluation of in vitro effect on Leishmania major
por: Rahnama, Vahid, et al.
Publicado: (2021)

Evaluation of vancomycin therapy in the adult ICUs of a teaching hospital in southern Iran
por: Vazin, Afsaneh, et al.
Publicado: (2018)

Effect of First Trough Vancomycin Concentration on the Occurrence of AKI in Critically Ill Patients: A Retrospective Study of the MIMIC-IV Database
por: Li, Longzhu, et al.
Publicado: (2022)

Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and In Vivo Histopathological Studies
por: Mousavi-Simakani, Seyedeh Maryam, et al.
Publicado: (2023)

Vancomycin Utilization Evaluation at Hematology-Oncology Ward of a Teaching Hospital in Iran
por: Vazin, Afsaneh, et al.
Publicado: (2012)

Predictors of renal recovery in critically ill patients with AKI: observations from the ongoing FBI clinical trial
por: Robinson, S, et al.
Publicado: (2015)

Hepatic drug metabolism by CYP2D6 in critically ill adults with AKI: effect of phenotype and AKI severity
por: Lane, K, et al.
Publicado: (2015)

Evaluation of Factors Associated with Hypermetabolism and Hypometabolism in Critically Ill AKI Patients
por: de Góes, Cassiana R., et al.
Publicado: (2018)

Urine Complement Factor Ba Is Associated with AKI in Critically Ill Children
por: Stenson, Erin K., et al.
Publicado: (2023)

Nutritional Assessment in Critically Ill Patients
por: Hejazi, Najmeh, et al.
Publicado: (2016)

Predictors of acute kidney injury under continuous infusion of vancomycin in critically ill surgical patients
por: Chackupurakal, R, et al.
Publicado: (2015)

Urinary TIMP-2 and IGFBP7 elevate early in critically ill postoperative patients that develop AKI
por: Honore, P, et al.
Publicado: (2015)

Evaluating Adherence of Health-Care Team to Standard Guideline of Colistin Use at Intensive Care Units of a Referral Hospital in Shiraz, Southwest of Iran
por: Vazin, Afsaneh, et al.
Publicado: (2017)

The Serum Concentration of Vancomycin as a Diagnostic Predictor of Nephrotoxic Acute Kidney Injury in Critically Ill Patients
por: Zamoner, Welder, et al.
Publicado: (2022)

2416: A machine learning pipeline to predict acute kidney injury (AKI) in patients without AKI in their most recent hospitalization
por: Weisenthal, Samuel, et al.
Publicado: (2018)

Impact of ideal versus estimated body weight on haemofiltration dosing in critically ill patients with AKI
por: Fischer, F, et al.
Publicado: (2014)

ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients
por: Truche, A. S., et al.
Publicado: (2018)

Serum IL-17 levels are higher in critically ill patients with AKI and associated with worse outcomes
por: Collett, Jason A., et al.
Publicado: (2022)

Neurological Impairment in Critically Ill Patients on Dialysis: Research Letter for the INCOGNITO-AKI Feasibility Study
por: Jawa, Natasha A., et al.
Publicado: (2023)

Drug-based therapeutic strategies for COVID-19-infected patients and their challenges
por: Zarkesh, Khatereh, et al.
Publicado: (2021)

Subclinical AKI is still AKI
por: Ronco, Claudio, et al.
Publicado: (2012)

p53 activates miR-192-5p to mediate vancomycin induced AKI
por: Chen, Jinwen, et al.
Publicado: (2016)

Usefulness of vancomycin serum concentration monitoring in the critically ill patient
por: Bertolissi, M, et al.
Publicado: (2000)

Vancomycin is commonly under‐dosed in critically ill children and neonates
por: Sosnin, Natasha, et al.
Publicado: (2019)

Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review
por: Akunne, Onyinye Onyeka, et al.
Publicado: (2021)

The Missing Link Between Coffee Consumption and AKI–Water
por: Yates, Brandon A., et al.
Publicado: (2022)

Comparison of Race‐Based and Non–Race‐Based Equations for Kidney Function Estimation in Critically Ill Thai Patients for Vancomycin Dosing
por: Sitaruno, Sirima, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_atole6b8tcc4t2kef5abr32eur